Cancer Research Cell Death Mechanisms and Cancer Therapy  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tuxhorn, J. A.
Right arrow Articles by Rowley, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tuxhorn, J. A.
Right arrow Articles by Rowley, D. R.
[Cancer Research 62, 6021-6025, November 1, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

Inhibition of Transforming Growth Factor-ß Activity Decreases Angiogenesis in a Human Prostate Cancer-reactive Stroma Xenograft Model1

Jennifer A. Tuxhorn, Stephanie J. McAlhany, Feng Yang, Truong D. Dang and David R. Rowley2

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030

We have shown previously that reactive stroma promotes angiogenesis and growth of LNCaP human prostate tumors in the differential reactive stroma xenograft model. Regulators of reactive stroma are not known, but transforming growth factor (TGF)-ß1 is a likely candidate. Three-way differential reactive stroma tumors were generated in the presence of TGF-ß1 latency-associated peptide (LAP) or TGF-ß1 neutralizing antibody. Tumors treated with either of those TGF-ß inhibitors exhibited a reduction in blood vessels, and blood lakes were observed in some areas. The microvessel density of LAP-treated tumors was decreased 3.5-fold relative to control tumors. Moreover, the average wet-weight of LAP-treated tumors was reduced 46% compared with control tumors. The results of this study suggest that TGF-ß regulates reactive stroma and its ability to promote angiogenesis and tumor growth.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
H. Neuwirt, M. Puhr, F. R. Santer, M. Susani, W. Doppler, G. Marcias, V. Rauch, M. Brugger, A. Hobisch, L. Kenner, et al.
Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases
Am. J. Pathol., May 1, 2009; 174(5): 1921 - 1930.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
B. A Teicher, J. M Yingling, and J. M McPherson
TGF{beta} Blockade as Anticancer Therapy
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 71 - 81.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. V. Verona, A. G. Elkahloun, J. Yang, A. Bandyopadhyay, I-T. Yeh, and L.-Z. Sun
Transforming Growth Factor-{beta} Signaling in Prostate Stromal Cells Supports Prostate Carcinoma Growth by Up-regulating Stromal Genes Related to Tissue Remodeling
Cancer Res., June 15, 2007; 67(12): 5737 - 5746.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. L. Cher, D. A. Towler, S. Rafii, D. Rowley, H. J. Donahue, E. Keller, M. Herlyn, E. A. Cho, and L. W.K. Chung
Cancer Interaction with the Bone Microenvironment: A Workshop of the National Institutes of Health Tumor Microenvironment Study Section
Am. J. Pathol., May 1, 2006; 168(5): 1405 - 1412.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. L. Tejada, L. Yu, J. Dong, K. Jung, G. Meng, F. V. Peale, G. D. Frantz, L. Hall, X. Liang, H.-P. Gerber, et al.
Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor {alpha} Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung Carcinoma.
Clin. Cancer Res., May 1, 2006; 12(9): 2676 - 2688.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kawada, H. Inoue, T. Masuda, and D. Ikeda
Insulin-like Growth Factor I Secreted from Prostate Stromal Cells Mediates Tumor-Stromal Cell Interactions of Prostate Cancer.
Cancer Res., April 15, 2006; 66(8): 4419 - 4425.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Rennebeck, M. Martelli, and N. Kyprianou
Anoikis and Survival Connections in the Tumor Microenvironment: Is There a Role in Prostate Cancer Metastasis?
Cancer Res., December 15, 2005; 65(24): 11230 - 11235.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Bertolino, M. Deckers, F. Lebrin, and P. ten Dijke
Transforming Growth Factor-{beta} Signal Transduction in Angiogenesis and Vascular Disorders
Chest, December 1, 2005; 128(6_suppl): 585S - 590S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Bertolino, M. Deckers, F. Lebrin, and P. ten Dijke
Transforming Growth Factor-{beta} Signal Transduction in Angiogenesis and Vascular Disorders
Chest, December 1, 2005; 128(6_suppl): 585S - 590S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Yang, J. A. Tuxhorn, S. J. Ressler, S. J. McAlhany, T. D. Dang, and D. R. Rowley
Stromal Expression of Connective Tissue Growth Factor Promotes Angiogenesis and Prostate Cancer Tumorigenesis
Cancer Res., October 1, 2005; 65(19): 8887 - 8895.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y. Zeng, K. Opeskin, M. E. Baldwin, L. G. Horvath, M. G. Achen, S. A. Stacker, R. L. Sutherland, and E. D. Williams
Expression of Vascular Endothelial Growth Factor Receptor-3 by Lymphatic Endothelial Cells Is Associated with Lymph Node Metastasis in Prostate Cancer
Clin. Cancer Res., August 1, 2004; 10(15): 5137 - 5144.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. G. Deane, H. Lee, J. Hamaamen, A. Ruley, M. K. Washington, B. LaFleur, S. S. Thorgeirsson, R. Price, and R. D. Beauchamp
Enhanced Tumor Formation in Cyclin D1 x Transforming Growth Factor {beta}1 Double Transgenic Mice with Characterization by Magnetic Resonance Imaging
Cancer Res., February 15, 2004; 64(4): 1315 - 1322.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Walter-Yohrling, X. Cao, M. Callahan, W. Weber, S. Morgenbesser, S. L. Madden, C. Wang, and B. A. Teicher
Identification of Genes Expressed in Malignant Cells That Promote Invasion
Cancer Res., December 15, 2003; 63(24): 8939 - 8947.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. J. McAlhany, S. J. Ressler, M. Larsen, J. A. Tuxhorn, F. Yang, T. D. Dang, and D. R. Rowley
Promotion of Angiogenesis by ps20 in the Differential Reactive Stroma Prostate Cancer Xenograft Model
Cancer Res., September 15, 2003; 63(18): 5859 - 5865.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.